"May 1, 2020. FDAn issued an emergency use authorization for the investigational antiviral drug remdesivir for the treatment COVID-19 in adults and children hospitalized with severe disease."

"On October 22, 2020, FDA approved Veklury (remdesivir) for use in adults and pediatric patients".